[44Sc]Sc-B28110 shows preclinical promise as a radiotracer for the imaging of prostate cancer Sep. 8, 2021
Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism Aug. 31, 2021
Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer Aug. 26, 2021
Labile iron pool radiotracer [18F]TRX can predict sensitivity to iron-targeted tumor therapies Aug. 6, 2021
89Zr-Immuno-PET using bispecific Abeta MAb as promising diagnostic strategy for Alzheimer's disease Aug. 5, 2021
RSS